Dexmedetomidine protects H9C2 against hypoxia/reoxygenation injury through miR-208b-3p/Med13/Wnt signaling pathway axis.

Biomedicine & Pharmacotherapy(2020)

Cited 22|Views4
No score
Abstract
•miR-208b-3p is upregulated in H9C2 undergoing Hypoxia/reoxygenation.•Dexmedetomidine reduces upregulation of miR-208b-3p caused by Hypoxia/reoxygenation in H9C2.•Med13 is a direct target gene of miR-208b-3p.•Dexmedetomidine induces protective effect on H9C2 via miR-208b-3p/Med13/Wnt/β-catenin signaling pathway axis.
More
Translated text
Key words
AMI,CABG,Dex,DMEM,ECL,FBS,HR,I/R,miRNAs,MI,PCI,PMSF,PVDF,qRT-PCR,UTR
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined